Real-time enrollment status for this myeloid malignancies clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 3:28 AM UTC
| NCT Number | NCT04771130 |
| Recruiting Status | Recruiting |
| Condition | Myeloid Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 260 participants |
| Active Locations | 5 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | July 13, 2026 (6 days ago) |
As of July 19, 2026: Clinical trial NCT04771130 is currently recruiting participants. This phase1 study for myeloid malignancies is actively seeking new participants at 5 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04771130 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04771130 was last updated 6 days ago (July 13, 2026). HelloStudys verifies this status automatically.